Evidence in medulloblastomas

Clinical and Translational Oncology

Volumn 12, Issue 4, 2010, Pages 271-277

  Navajas, Aurora ^a   Giralt, Jordi ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Chemotherapy; Children; Evidences; Medulloblastoma; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MESNA; METHOTREXATE; VINCRISTINE;

AGE; ANASTOMOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; ENDOSCOPIC SURGERY; GENETIC MARKER; HIGH RISK PATIENT; HUMAN; HYDROCEPHALUS; MEDULLOBLASTOMA; MOLECULAR BIOLOGY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PEDIATRICS; REVIEW;

ANTINEOPLASTIC AGENTS; CEREBELLAR NEOPLASMS; CHILD; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; MEDULLOBLASTOMA; NEUROSURGICAL PROCEDURES; RADIOTHERAPY;

EID: 77952131019     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0503-y     Document Type: Review

References (48)

1. Giangaspero F, Eberhart CG, Haapasalo et al (2007) In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, Medulloblastoma pp 132-140
2. D.E. McNeil T.R. Cote L. Ciegg, et al. 2002 Incidence and trends in pediatric malignancies, medulloblastoma/primitive neuroectodermal tumor: a SEER update, Surveillance Epidemiology and End Results Med Pediatr Oncol 39 190 194 10.1002/mpo.10121 12210449 (Pubitemid 34827569)
3. R. Peris Bonet C. Martinez-García B. Lacour S. Petrovich B. Giner Ripoll A. Navajas E. Steliarova-Foucher 2006 Childhood central nervous system tumours, incidence and survival in Europe (1978-1997). Report from Automated Childhood Cancer Information System Project Eur J Cancer 42 2064 2080 10.1016/j.ejca.2006.05.009 16919771 (Pubitemid 44224055)
4. Z. García A. Echebarría A. Urberuaga I. Astigarraga J. Burgos A. Navajas 2009 Differential aspects in children and adult patients with medulloblastoma Med Clin (Barc) 133 454 459 10.1016/j.medcli.2009.06.011
5. S. Pfister M. Remke G. Toedt, et al. 2007 Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas Genes Chromosomes Cancer 46 839 851 10.1002/gcc.20471 1:CAS:528:DC%2BD2sXotlCht7w%3D 17592618 (Pubitemid 47106188)
6. A. Navajas A. Fernández Teijeiro 2005 Embryonic tumours of the central nervous System Clin Transl Oncol 7 219 227 10.1007/BF02712821
7. A. Urberuaga A. Navajas J. Burgos J.I. Pijoán 2006 A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years Childs Nerv Sys 22 466 474 10.1007/s00381-005-0004-4
8. A.C. Peet M.O. Leach C.R. Pinkerton, et al. 2005 Proceedings of the Engineering and Physical Sciences Research Council Workshop The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours. Pediatr Blood Cancer 44 103 113 1:STN:280:DC%2BD2cnisVaqtQ%3D%3D
9. C.H. Chang E.M. Housepian C. Herbert Jr. 1969 An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas Radiology 93 1351 1359 1:STN:280:DyaE3c%2FnvVOhtQ%3D%3D 4983156
10. M.A. Grotzer A.J. Janss K. Fung, et al. 2000 TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors J Clin Oncol 18 1027 1035 1:CAS:528:DC%2BD3cXitVCgsLg%3D 10694553
11. D.W. Ellison S.C. Clifford A. Gajjar, et al. 2003 Recent advances in medulloblastoma Eur J Ped Neurol 7 53 66 10.1016/S1090-3798(03)00014-X (Pubitemid 36519473)
12. A. Gajjar R. Herman M. Kocak, et al. 2004 Clinical, histopathologic and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma J Clin Oncol 22 984 993 10.1200/JCO.2004.06.032 1:CAS:528:DC%2BD2cXptlCkurs%3D 14970185 (Pubitemid 41095029)
13. A. Fernández-Teijeiro R.A. Betensky L.M. Sturla, et al. 2004 Combining gene expresión profiles and clinical parameters for risk stratification in medulloblastomas J Clin Oncol 22 994 998 10.1200/JCO.2004.03. 036 14970184 (Pubitemid 41095030)
14. R.J. Gilbertson 2004 Medulloblastoma: signalling a change in treatment Lancet Oncol 5 209 218 10.1016/S1470-2045(04)01424-X 15050952 (Pubitemid 38391216)
15. A. Cvekl Jr J. Zavadil B.K. Birshtein, et al. 2004 Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene Eur J Cancer 40 2525 2532 10.1016/j.ejca.2004.08.005 1:CAS:528:DC%2BD2cXptFKrsL4%3D 15519529 (Pubitemid 39424970)
16. B.L. Pizer S.C. Clifford 2009 The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials Br J Neurosurg 23 364 375 10.1080/02688690903121807 19637007
17. S. Pfister M. Remke A. Benner, et al. 2009 Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci J Clin Oncol 27 1627 1636 10.1200/JCO.2008.17.9432 19255330
18. P.K. Duffner M.E. Horowitz J.P. Krischer, et al. 1993 Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours N Engl J Med 328 1725 1731 10.1056/NEJM199306173282401 1:STN:280:DyaK3s3mvVensw%3D%3D 8388548 (Pubitemid 23170121)
19. B.R. Rood T.J. Mac Donald R.J. Packer 2004 Current treatment of medulloblastoma: recent advances and future challenges Semin Oncol 31 666 675 10.1053/j.seminoncol.2004.07.009 15497120 (Pubitemid 39389018)
20. J. Grill C. Sainte-Rose A. Jouvet, et al. 2005 Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children Lancet Oncol 6 573 580. 10.1016/S1470-2045(05)70252-7 1:CAS:528:DC%2BD2MXmvVWmtrw%3D 16054568 (Pubitemid 41051935)
21. S. Rutowski U. Bode F. Deinlein, et al. 2005 Treatment of early childhood medulloblastoma by postoperative chemotherapy alone N Engl J Med 352 978 986 10.1056/NEJMoa042176 (Pubitemid 40349500)
22. D.L. Johnston D. Keene U. Bartels, et al. 2009 Medulloblastoma in children under the age of three years: a retrospective Canadian review J Neuro Oncol 94 51 56 10.1007/s11060-009-9799-2
23. K. Von Hoff B. Hinkes N. Gerber, et al. 2009 Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomized multicentre trial HIT91 Eur J Cancer 45 1209 1217 10.1016/j.ejca.2009.01.015
24. K. Von Hoff W. Hartmann A.O. von Bueren, et al. 2010 Large cell/anaplastic medulloblastoma: outcome according to Myc status, histopathological, and clinical risk factors Pediatr Blood Cancer 54 369 376 10.1002/pbc.22339
25. R. Bathia M. Tahir C.L. Chandler 2009 The management of hydrocephalus in children with posterior fossa tumours: the role of pre-resectional endoscopic third ventriculostomy Pediatr Neurosurg 45 186 191 10.1159/000222668
26. D. Kombogiorgas K. Natarajan S. Sgouros 2008 Predictive value of preoperative ventricular volume on the need for permanent hydrocephalus treatment immediately after resection of posterior fossa medulloblastomas in children J Neurosurg Pediatr 1 451 455 10.3171/PED/2008/1/6/451 18518695 (Pubitemid 351798834)
27. M.M. Souweidane P.F. Morgenstern P.J. Cristos, et al. 2009 Intraoperative arachnoid and cerebrospinal fluid sampling in children with posterior fossa brain tumours Neurosurgery 65 72 78 10.1227/01.NEU.0000348011.98625.43 19574827
28. D.M. Tait H. Thornton-Jones H.J. Bloom, et al. 1990 Adjuvant chemotherapy for medulloblastoma: the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP) Eur J Cancer 26 464 469 1:STN:280:DyaK3c3ptV2isw%3D%3D 2141512
29. P.M. Zeltzer J.M. Boyett J.L. Finlay, et al. 1999 Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastomas in children: conclusions from the Children's Cancer Group 921 randomized phase III study J Clin Oncol 17 832 845 1:CAS:528:DyaK1MXhvFGgur0%3D 10071274
30. R.D. Kortmann J. Kuhl B. Timmerman, et al. 2000 Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT 91 Int J Radiat Oncol Biol Phys 46 269 279 10.1016/S0360-3016(99)00369-7 1:STN:280: DC%2BD3c7isV2nug%3D%3D 10661332 (Pubitemid 30067775)
31. R.E. Taylor C.C. Bailey K. Robinson, et al. 2003 Results of a randomised study of pre-radiotherapy chemotherapy vs radiotherapy alone for non-metastatic (M0-1) medulloblastoma. The SIOP/UKCCSG PNET-3 study J Clin Oncol 21 1581 1591 10.1200/JCO.2003.05.116 1:CAS:528:DC%2BD2cXptlCksLk%3D 12697884 (Pubitemid 46594113)
32. S.L. Palmer O. Goloubeva W.E. Reddick, et al. 2001 Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis J Clin Oncol 19 2302 2308 1:STN:280:DC%2BD3M3mtFOgsw%3D%3D 11304784
33. R.K. Mulhern S.L. Palmer T.E. Merchant, et al. 2005 Neurocognitive consequences of riskadapted therapy for childhood medulloblastoma: attention and memory functioning among pediatric patients with medulloblastoma J Clin Oncol 23 5511 5519 10.1200/JCO.2005.00.703 16110011
34. H.A. Spoudeas E. Charmandari C.G. Brook 2003 Hypothalamo-pituitary- adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours Med Pediatr Oncol 40 224 229 10.1002/mpo.10267 1:STN:280: DC%2BD3s%2FksFCiuw%3D%3D 12555249 (Pubitemid 36222827)
35. P.R.M. Thomas M. Deutsch J. Kepner, et al. 2000 Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduceddose neuraxis irradiation J Clin Oncol 18 3004 3011 1:STN:280: DC%2BD3cvivFCktw%3D%3D 10944134
36. R.J. Packer J. Goldwein H.S. Nicholson, et al. 1999 Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study J Clin Oncol 17 2127 2136 1:CAS:528:DyaK1MXkvVSmur8%3D 10561268
37. R.J. Packer A. Gajjar G. Vezina, et al. 2006 Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastomas J Clin Oncol 24 4202 4208 10.1200/JCO.2006.06.4980 1:CAS:528:DC%2BD28XhtVantbvF 16943538 (Pubitemid 46622300)
38. J.O. del Charco T.W. Bolek W.M. McCollough, et al. 1998 Medulloblastoma: time-dose relationship based on a 30-year review Int J Radiat Oncol Biol Phys 42 147 154 9747832
39. L. Gandola M. Massimino G. Cefalo, et al. 2009 Hyperfractionated accelerated radiotherapy in the Milan Strategy for Metastatic Medulloblastoma J Clin Oncol 27 566 571 10.1200/JCO.2008.18.4176 1:CAS:528:DC%2BD1MXivFyjurs%3D 19075266
40. R.E. Taylor N. Boota S. Bujkiewicz, et al. 2009 Children's Cancer and Leukemia Group (CCLG) Study of Hyperfractionated Accelerated Radiotherapy (HART) with Chemotherapy for M1-3 Medulloblastoma (MB) Int J Radiat Oncol Biol Phys 275 S38
41. Ater J (2007) In: Pinkerton R, Shankar AG, Matthay K (eds) Evidence-based pediatric oncology, 2nd edn, Blackwell, Oxford, Medulloblastoma pp 125-149
42. T.E. Merchant L.E. Kun M.J. Krasin, et al. 2008 Multiinstitutional prospective trial of reduceddose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8Gy) and dose intensive chemotherapy for average risk medulloblastoma Int J Radiat Oncol Biol Phys 70 782 787 17892918
43. I.J. Dunkel S.L. Gardner J.H. Garvin, et al. 2010 High dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma Neuro Oncol 12 297 303 20167818
44. Gajjar A, Chintagumpala M, Ashley D et al Riskadapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96): Long-term results from a prospective multicentre trial. Lancet Oncol 7:813-820
45. R. Taylor C.C. Bailey K.J. Robinson, et al. 2004 Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma Int J Radiat Oncol Biol Phys 58 1148 1193 10.1016/S0360-3016(03)01575-X (Pubitemid 38016222)
46. W.H. St Clair J.A. Adams M. Bues, et al. 2004 Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma Int J Radiat Oncol Biol Phys 58 727 734 1:STN:280:DC%2BD2c%2FnvVaisw%3D%3D 14967427
47. Carrie C, Grill J, Figarella-Branger D et al On line quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. J Clin Oncol 27:1879-1883
48. B. Lannering S. Rurkowski G. Gustafsson, et al. 2008 HIT-SIOP PNET-IV: A randomized multicenter study of hyperfractionated versus conventional radiotherapy in children with standard-risk medulloblastoma Neuro Oncol 10 480